Among them, IL-2, including aldesleukin, has the potential to trigger a severe capillary leak syndrome, leading to edema, depletion of plasma volume, and a reversible decline in glomerular filtration rate, which is primarily attributed to hypovolemia and can therefore result in AKI25. Here, IL2 is linked to capillary leak syndrome.